About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Kineret CAPS Post Authorisation Study | Clinical Trials | Clareo Health

Back to clinical trial search

COMPLETEDNCT02326376

Kineret CAPS Post Authorisation Study

A non-interventional, post authorization safety study to evaluate the safety of Kineret in the treatment of Cryopyrin Associated Periodic Syndromes (CAPS) in routine clinical care with regard to serio...

Lead sponsor: Swedish Orphan Biovitrum•2 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Sponsors

Lead Sponsor

Swedish Orphan Biovitrum

Collaborators

Pediatric Rheumatology International Trials Organization

Age

All ages

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•Informed consent by the patient and/or caregiver
•Kineret treatment will be according to the Summary of Product Characteristics (SmPC), as confirmed by the Investigator

Exclusion Criteria

•None

Related studies

RECRUITINGPhase 1

Repeat PET/CT Imaging in People With CAPS and Anakinra-Induced Amyloidosis Using an Amyloid-Reactive Peptide to Measure Changes in Organ-Specific Amyloid Load

NCT06974877 · Cryopyrin-Associated Periodic Syndromes, Amyloidosis

Ilaris NIS in Korea

NCT06838143 · Hereditary Periodic Fever Syndromes, Cryopyrin-associated Periodic Syndromes (CAPS), and more

Phenomics in Autoimmune and Inflammatory Diseases

NCT02466217 · Healthy Volunteer, Rheumatoid Arthritis, and more

COMPLETEDPhase 3

Efficacy and Safety Study of Canakinumab Administered for 6 Months (24 Weeks) in Japanese Patients With Cryopyrin-associated Periodic Syndromes Followed by an Extension Phase

NCT00991146 · Cryopyrin-associated Periodic Syndromes, Familial Cold Autoinflammatory Syndrome, and more

COMPLETEDPhase 3

Efficacy and Safety of ACZ885 in Patients With the Following Cryopyrin-associated Periodic Syndromes: Familial Cold Autoinflammatory Syndrome, Muckle-Wells Syndrome, or Neonatal Onset Multisystem Inflammatory Disease

NCT00685373 · Cryopyrin-Associated Periodic Syndromes, Familial Cold Autoinflammatory Syndrome, and more

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: January 18, 2020Terms

Trial snapshot

StatusCOMPLETED

Phase—

Enrollment12

Start dateApr 2015

Last updatedJan 18, 2020

Condition

Cryopyrin-Associated Periodic Syndromes

Locations shown

Swedish Orphan Biovitrum Investigational Site

Groningen

Swedish Orphan Biovitrum Investigational Site

London

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: January 18, 2020Data synced to Clareo: May 25, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions